Boston Scientific Corporation ( BSX) - Key Metrics
BSX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $3.68 | $0.61 | $1 | $0.87 |
| 2026Q1 | $3.50 | $0.90 | $0.23 | $0.12 |
| 2025Q4 | $3.57 | $0.45 | $0.92 | $0.68 |
| 2025Q3 | $3.42 | $0.51 | $0.91 | $0.78 |
| 2025Q2 | $3.42 | $0.54 | $0.87 | $0.74 |
BSX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 17.21 |
| 2026Q1 | 0% | 17.43 |
| 2025Q4 | 0% | 52.97 |
| 2025Q3 | 0% | 47.86 |
| 2025Q2 | 0% | 49.73 |
BSX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 2.03% | 0% |
| 2026Q1 | 0.18% | 0% |
| 2025Q4 | 0.72% | 0% |
| 2025Q3 | 0.80% | 0% |
| 2025Q2 | 0.69% | 0% |
BSX
Price: $42.18
52 week price:
Payout Ratio Range:
Earnings Per Share: 2.47 USD
P/E Ratio: 19.61
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 13.0 million
Ebitda: 425.0 millionMarket Capitalization: 63.0 billion